Karin Hohloch Selected Research

4-demethoxyanthracycline

1/2014

Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Hohloch Research Topics

Disease

7	Lymphoma (Lymphomas) 01/2019 - 11/2007
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2022 - 09/2011
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2016 - 01/2009
2	COVID-19 01/2021 - 01/2020
2	Neoplasms (Cancer) 07/2019 - 10/2011
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2014 - 11/2011
1	Thrombocytopenia (Thrombopenia) 12/2022
1	Neutropenia 04/2021
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021
1	Exanthema (Rash) 01/2021
1	Hemolysis 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2020
1	Wounds and Injuries (Trauma) 07/2019
1	Brain Injuries (Brain Injury) 07/2019
1	Hematoma 07/2019
1	Hyponatremia 07/2019
1	Inappropriate ADH Syndrome (SIADH) 07/2019
1	Thrombocytosis (Thrombocythemia) 07/2019
1	Wasting Syndrome (Wasting Disease) 07/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2014
1	Cardiotoxicity 01/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2009
1	Multiple Myeloma 07/2007

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 12/2018 - 11/2011
2	obinutuzumabIBA 12/2022 - 08/2019
2	venetoclaxIBA 12/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 11/2007
2	Radioisotopes (Radionuclides)IBA 01/2009 - 11/2007
2	Monoclonal AntibodiesIBA 01/2009 - 11/2007
1	Acyclovir (Aciclovir)FDA LinkGeneric 04/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	SaltsIBA 07/2019
1	SodiumIBA 07/2019
1	Vasopressins (Vasopressin)IBA 07/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Vincristine (Oncovin)FDA LinkGeneric 01/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014
1	4-demethoxyanthracyclineIBA 01/2014
1	Prednisone (Sone)FDA LinkGeneric 01/2014
1	Etoposide (VP 16)FDA LinkGeneric 01/2014
1	Methylprednisolone FDA LinkGeneric 03/2013
1	Cisplatin (Platino)FDA LinkGeneric 10/2011
1	Alemtuzumab (Campath)FDA Link 08/2009
1	fludarabineIBA 08/2009
1	ibritumomab tiuxetan (Zevalin)FDA Link 11/2007
1	YttriumIBA 11/2007
1	Melphalan (Alkeran)FDA LinkGeneric 07/2007

Therapy/Procedure

8	Therapeutics 12/2022 - 01/2009
7	Radioimmunotherapy 05/2020 - 01/2009
2	Radiotherapy 08/2019 - 12/2018
2	Stem Cell Transplantation 06/2016 - 11/2011
2	Drug Therapy (Chemotherapy) 11/2011 - 10/2011
1	Prostheses and Implants (Prosthesis) 07/2019
1	Salvage Therapy 11/2011
1	Dexa-BEAM protocol 11/2011
1	Immunotherapy 11/2007